These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 17476865)
21. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. Guajardo-Salinas GE; Hilmy A Obes Surg; 2010 Dec; 20(12):1647-53. PubMed ID: 19957049 [TBL] [Abstract][Full Text] [Related]
23. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783 [TBL] [Abstract][Full Text] [Related]
24. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957 [TBL] [Abstract][Full Text] [Related]
25. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Stratopoulos C; Papakonstantinou A; Terzis I; Spiliadi C; Dimitriades G; Komesidou V; Kitsanta P; Argyrakos T; Hadjiyannakis E Obes Surg; 2005 Sep; 15(8):1154-60. PubMed ID: 16197789 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery. Liang RJ; Wang HH; Lee WJ; Liew PL; Lin JT; Wu MS Obes Surg; 2007 Jan; 17(1):45-56. PubMed ID: 17355768 [TBL] [Abstract][Full Text] [Related]
28. Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients. Kroh M; Liu R; Chand B Surg Endosc; 2007 Nov; 21(11):1957-60. PubMed ID: 17479322 [TBL] [Abstract][Full Text] [Related]
30. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898 [TBL] [Abstract][Full Text] [Related]
31. Clinical predictors of different grades of nonalcoholic fatty liver disease. Júnior WS; Nonino-Borges CB Obes Surg; 2012 Feb; 22(2):248-52. PubMed ID: 21598007 [TBL] [Abstract][Full Text] [Related]
32. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience. Reha JL; Lee S; Hofmann LJ Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798 [TBL] [Abstract][Full Text] [Related]
33. Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity. de Oliveira CP; de Mello ES; Alves VA; Saviero SM; Strauss E Ann Hepatol; 2007; 6(4):255-61. PubMed ID: 18007556 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Qureshi K; Abrams GA Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683 [TBL] [Abstract][Full Text] [Related]
36. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Moretto M; Kupski C; Mottin CC; Repetto G; Garcia Toneto M; Rizzolli J; Berleze D; de Souza Brito CL; Casagrande D; Colossi F Obes Surg; 2003 Aug; 13(4):622-4. PubMed ID: 12940291 [TBL] [Abstract][Full Text] [Related]
37. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months. Keshishian A; Zahriya K; Willes EB Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521 [TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Dixon JB; Bhathal PS; O'Brien PE Gastroenterology; 2001 Jul; 121(1):91-100. PubMed ID: 11438497 [TBL] [Abstract][Full Text] [Related]